CVE Vulnerability

CVE-2022-30277

BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII).

3.6 /10

CVSS v2.0 :

V3 Legend

Vector :

Exploitability : 3.9 / Impact : 4.9

Attack Vector

Attack Complexity

Privileges Required

User Interaction

Confidentiality Impact PARTIAL

Integrity Impact PARTIAL

Availability Impact NONE

Scope

5.7 /10

CVSS v3.0 : MEDIUM

V3 Legend

Vector :

Exploitability : 0.5 / Impact : 5.2

Attack Vector PHYSICAL

Attack Complexity LOW

Privileges Required LOW

User Interaction REQUIRED

Confidentiality Impact HIGH

Integrity Impact HIGH

Availability Impact NONE

Scope UNCHANGED

References
Link Resource
https://cybersecurity.bd.com/bulletins-and-patches/bd-synapsys-insufficient-session-expiration Vendor Advisory
Configurations

Configuration 1

cpe:2.3:a:bd:synapsys:4.30:*:*:*:*:*:*:*
cpe:2.3:a:bd:synapsys:4.20:sr1:*:*:*:*:*:*
cpe:2.3:a:bd:synapsys:4.20:-:*:*:*:*:*:*
Information

Published : 2022-06-02 02:15

Updated : 2022-06-10 02:14

NVD link : CVE-2022-30277

Mitre link : CVE-2022-30277

Products Affected
No products.
CWE
CWE-613